Literature DB >> 25801561

N-acetylcysteine selectively antagonizes the activity of imipenem in Pseudomonas aeruginosa by an OprD-mediated mechanism.

Jerónimo Rodríguez-Beltrán1, Gabriel Cabot2, Estela Ynés Valencia1, Coloma Costas1, German Bou3, Antonio Oliver4, Jesús Blázquez5.   

Abstract

The modulating effect of N-acetylcysteine (NAC) on the activity of different antibiotics has been studied in Pseudomonas aeruginosa. Our results demonstrate that, in contrast to previous reports, only the activity of imipenem is clearly affected by NAC. MIC and checkerboard determinations indicate that the NAC-based modulation of imipenem activity is dependent mainly on OprD. SDS-PAGE of outer membrane proteins (OMPs) after NAC treatments demonstrates that NAC does not modify the expression of OprD, suggesting that NAC competitively inhibits the uptake of imipenem through OprD. Similar effects on imipenem activity were obtained with P. aeruginosa clinical isolates. Our results indicate that imipenem-susceptible P. aeruginosa strains become resistant upon simultaneous treatment with NAC and imipenem. Moreover, the generality of the observed effects of NAC on antibiotic activity was assessed with two additional bacterial species, Escherichia coli and Acinetobacter baumannii. Caution should be taken during treatments, as the activity of imipenem may be modified by physiologically attainable concentrations of NAC, particularly during intravenous and nebulized regimes.
Copyright © 2015, American Society for Microbiology. All Rights Reserved.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25801561      PMCID: PMC4432192          DOI: 10.1128/AAC.00017-15

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  31 in total

1.  Negative regulation of the Pseudomonas aeruginosa outer membrane porin OprD selective for imipenem and basic amino acids.

Authors:  M M Ochs; M P McCusker; M Bains; R E Hancock
Journal:  Antimicrob Agents Chemother       Date:  1999-05       Impact factor: 5.191

2.  N-ACETYL-L-CYSTEINE AS LIQUEFYING AGENT IN THE BACTERIOLOGICAL EXAMINATION OF SPUTUM.

Authors:  G R MEAD; A W WOODHAMS
Journal:  Tubercle       Date:  1964-12

3.  Outer membrane protein D2 catalyzes facilitated diffusion of carbapenems and penems through the outer membrane of Pseudomonas aeruginosa.

Authors:  J Trias; H Nikaido
Journal:  Antimicrob Agents Chemother       Date:  1990-01       Impact factor: 5.191

Review 4.  N-acetylcysteine -- passe-partout or much ado about nothing?

Authors:  Mirja-Liisa Aitio
Journal:  Br J Clin Pharmacol       Date:  2006-01       Impact factor: 4.335

5.  Influence of N-acetylcysteine on the formation of biofilm by Staphylococcus epidermidis.

Authors:  C Pérez-Giraldo; A Rodríguez-Benito; F J Morán; C Hurtado; M T Blanco; A C Gómez-García
Journal:  J Antimicrob Chemother       Date:  1997-05       Impact factor: 5.790

6.  Effect of pathological changes of pH, pO2 and pCO2 on the activity of antimicrobial agents in vitro.

Authors:  C König; H P Simmen; J Blaser
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1993-07       Impact factor: 3.267

7.  The disposition and kinetics of intravenous N-acetylcysteine in patients with paracetamol overdosage.

Authors:  L F Prescott; J W Donovan; D R Jarvie; A T Proudfoot
Journal:  Eur J Clin Pharmacol       Date:  1989       Impact factor: 2.953

8.  N-acetylcysteine, a novel treatment for Helicobacter pylori infection.

Authors:  Hien Quoc Huynh; Richard T L Couper; Cuong D Tran; Lynette Moore; Richard Kelso; Ross N Butler
Journal:  Dig Dis Sci       Date:  2004 Nov-Dec       Impact factor: 3.199

9.  N-acetylcysteine in cystic fibrosis and Pseudomonas aeruginosa infection: clinical score, spirometry and ciliary motility.

Authors:  G Stafanger; C Koch
Journal:  Eur Respir J       Date:  1989-03       Impact factor: 16.671

10.  Construction of Escherichia coli K-12 in-frame, single-gene knockout mutants: the Keio collection.

Authors:  Tomoya Baba; Takeshi Ara; Miki Hasegawa; Yuki Takai; Yoshiko Okumura; Miki Baba; Kirill A Datsenko; Masaru Tomita; Barry L Wanner; Hirotada Mori
Journal:  Mol Syst Biol       Date:  2006-02-21       Impact factor: 11.429

View more
  7 in total

1.  Nitric oxide-releasing alginates as mucolytic agents.

Authors:  Mona Jasmine R Ahonen; David B Hill; Mark H Schoenfisch
Journal:  ACS Biomater Sci Eng       Date:  2019-05-24

2.  Effect of High N-Acetylcysteine Concentrations on Antibiotic Activity against a Large Collection of Respiratory Pathogens.

Authors:  Giulia Landini; Tiziana Di Maggio; Francesco Sergio; Jean-Denis Docquier; Gian Maria Rossolini; Lucia Pallecchi
Journal:  Antimicrob Agents Chemother       Date:  2016-11-21       Impact factor: 5.191

3.  Susceptibility to Imipenem/Relebactam of Pseudomonas aeruginosa and Acinetobacter baumannii Isolates from Chinese Intra-Abdominal, Respiratory and Urinary Tract Infections: SMART 2015 to 2018.

Authors:  Hui Zhang; Peiyao Jia; Ying Zhu; Ge Zhang; Jingjia Zhang; Wei Kang; Simeng Duan; Weijuan Zhang; Qiwen Yang; Yingchun Xu
Journal:  Infect Drug Resist       Date:  2021-08-31       Impact factor: 4.003

4.  High Activity of N-Acetylcysteine in Combination with Beta-Lactams against Carbapenem-Resistant Klebsiella pneumoniae and Acinetobacter baumannii.

Authors:  Massimiliano De Angelis; Maria T Mascellino; Maria C Miele; Dania Al Ismail; Marisa Colone; Annarita Stringaro; Vincenzo Vullo; Mario Venditti; Claudio M Mastroianni; Alessandra Oliva
Journal:  Antibiotics (Basel)       Date:  2022-02-10

5.  Acquisition of resistance to ceftazidime-avibactam during infection treatment in Pseudomonas aeruginosa through D179Y mutation in one of two blaKPC-2 gene copies without losing carbapenem resistance.

Authors:  Patricia García; Bárbara Brito; Manuel Alcalde-Rico; José M Munita; Jose R W Martínez; Jorge Olivares-Pacheco; Valeria Quiroz; Aniela Wozniak
Journal:  Front Cell Infect Microbiol       Date:  2022-09-02       Impact factor: 6.073

Review 6.  N-Acetyl Cysteine as an Adjunct in the Treatment of Tuberculosis.

Authors:  Dawit A Ejigu; Solomon M Abay
Journal:  Tuberc Res Treat       Date:  2020-04-30

7.  In vitro activity of N-acetylcysteine against Stenotrophomonas maltophilia and Burkholderia cepacia complex grown in planktonic phase and biofilm.

Authors:  Simona Pollini; Vincenzo Di Pilato; Giulia Landini; Tiziana Di Maggio; Antonio Cannatelli; Samantha Sottotetti; Lisa Cariani; Stefano Aliberti; Francesco Blasi; Francesco Sergio; Gian Maria Rossolini; Lucia Pallecchi
Journal:  PLoS One       Date:  2018-10-01       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.